| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |